{
  "directed": true,
  "graph": {
    "annotation_list": {
      "PublicationType": [
        "Comment",
        "Research",
        "Review"
      ]
    },
    "annotation_pattern": {},
    "annotation_url": {
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno"
    },
    "document_metadata": {
      "authors": "Sandra Spalek",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright © 2018 Fraunhofer Institute SCAI, All rights reserved",
      "description": "Tau oligomers and tau toxicity in neurodegenerative disease by Ward et al., 2012",
      "licenses": "CC BY 4.0",
      "name": "Tau oligomers and tau toxicity in neurodegenerative disease",
      "version": "1.0.0"
    },
    "namespace_pattern": {},
    "namespace_url": {
      "CHEBI": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/chebi/chebi-20180106.belns",
      "CONSO": "https://raw.githubusercontent.com/pharmacome/conso/501ceccdc9a27d97edbdc48a89ebe8e1dd3626e9/export/conso-names.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/73688d6dc24e309fca59a1340dc9ee971e9f3baa/external/go-names.belns",
      "HGNC": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hgnc/hgnc-20180215.belns",
      "HP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20171108.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/1b20f0637c395f8aa89c2e2e342d7b704062c242/external/mesh-names.belns"
    },
    "path": "tau/ward2012.bel",
    "pybel_version": "0.14.10"
  },
  "links": [
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Extracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "AD (Alzheimer’s disease) is a progressive neurodegenerative disorder characterized by the extracellular accumulation of amyloid beta-peptide and the intracellular accumulation of tau",
      "key": "eda9352cbd250b08796449837e7584ad",
      "line": 45,
      "relation": "positiveCorrelation",
      "source": 4,
      "target": 28
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Extracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "AD (Alzheimer’s disease) is a progressive neurodegenerative disorder characterized by the extracellular accumulation of amyloid beta-peptide and the intracellular accumulation of tau",
      "key": "5d85014be39bbdd22b9468656bb221ab",
      "line": 45,
      "relation": "positiveCorrelation",
      "source": 28,
      "target": 4
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "AD (Alzheimer’s disease) is a progressive neurodegenerative disorder characterized by the extracellular accumulation of amyloid beta-peptide and the intracellular accumulation of tau",
      "key": "fbdc5125009db5be46cde7fb9397d45b",
      "line": 47,
      "relation": "positiveCorrelation",
      "source": 28,
      "target": 1
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Extracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "AD (Alzheimer’s disease) is a progressive neurodegenerative disorder characterized by the extracellular accumulation of senile plaques composed of Aβ (amyloid β-peptide) and the intracellular accumulation of the MAP (microtubuleassociated protein) tau into both non-filamentous and filamentous inclusions, such as NFTs (neurofibrillary tangles), NTs (neuropil threads) and NPs (neuritic plaques) [1,2]",
      "key": "cec55af8c33674cbabbaad84cd93f6b5",
      "line": 82,
      "relation": "positiveCorrelation",
      "source": 28,
      "target": 29
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "AD (Alzheimer’s disease) is a progressive neurodegenerative disorder characterized by the extracellular accumulation of senile plaques composed of Aβ (amyloid β-peptide) and the intracellular accumulation of the MAP (microtubuleassociated protein) tau into both non-filamentous and filamentous inclusions, such as NFTs (neurofibrillary tangles), NTs (neuropil threads) and NPs (neuritic plaques) [1,2]",
      "key": "0ae351cd355ec1ddd7709e335d7420c0",
      "line": 84,
      "relation": "association",
      "source": 28,
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "AD (Alzheimer’s disease) is a progressive neurodegenerative disorder characterized by the extracellular accumulation of senile plaques composed of Aβ (amyloid β-peptide) and the intracellular accumulation of the MAP (microtubuleassociated protein) tau into both non-filamentous and filamentous inclusions, such as NFTs (neurofibrillary tangles), NTs (neuropil threads) and NPs (neuritic plaques) [1,2]",
      "key": "ab2164ad2fd1c4303b28ec1767bf8597",
      "line": 85,
      "relation": "association",
      "source": 28,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "The tau protein becomes highly phosphorylated in AD and this is likely to induce a conformational change causing its detachment from microtubules and its accumulation in aggregates [3]",
      "key": "fa3c2d3f5013134f11cf3599635eb73d",
      "line": 98,
      "relation": "increases",
      "source": 28,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "TOC1’s immunoreactivity is greatly elevated in AD brains compared with healthy controls, but co-localizes best with early-stage markers for AD pathogenesis such as pS422 [16]",
      "key": "4c2f008586cd88420a6b60149b2c7a53",
      "line": 123,
      "relation": "increases",
      "source": 28,
      "target": 3
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "AD (Alzheimer’s disease) is a progressive neurodegenerative disorder characterized by the extracellular accumulation of amyloid beta-peptide and the intracellular accumulation of tau",
      "key": "5caa66844f12e95dec56cfd6e372ce76",
      "line": 47,
      "relation": "positiveCorrelation",
      "source": 1,
      "target": 28
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "Using a squid axoplasm assay, we have demonstrated that aggregated tau inhibits anterograde FAT (fast axonal transport), whereas monomeric tau has no effect",
      "key": "873fd97a50b1214bc7ec88c7d56bccbc",
      "line": 60,
      "relation": "decreases",
      "source": 1,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "We discovered that aggregated tau inhibits FAT only in the anterograde direction at physiological tau levels, whereas tau monomers had no effect on FAT in either direction, even at concentrations of tau >10-fold higher than",
      "key": "1050fbd8f28455dd9409fd215c9017ee",
      "line": 131,
      "relation": "decreases",
      "source": 1,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "However, when tau aggregates, this conformation is altered, exposing PAD and allowing activation of the PP1/GSK3 signalling pathway facilitating FAT inhibition [21]",
      "key": "830d648449d4e6e6680f9bff13555087",
      "line": 164,
      "relation": "decreases",
      "source": 1,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "However, when tau aggregates, this conformation is altered, exposing PAD and allowing activation of the PP1/GSK3 signalling pathway facilitating FAT inhibition [21]",
      "key": "2cbc4e40da45b39a33f96fa24ff1266d",
      "line": 162,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 1,
      "target": 26
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "However, when tau aggregates, this conformation is altered, exposing PAD and allowing activation of the PP1/GSK3 signalling pathway facilitating FAT inhibition [21]",
      "key": "ac585adec5c7db881be01c43f1868a4c",
      "line": 163,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 1,
      "target": 18
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "TNT1 also co-localizes in tissue with the phospho-epitope defined by the AT8 antibody, indicating that PAD exposure represents an early event in AD pathology",
      "key": "c3ff737349e3ad020349b0bc638244ce",
      "line": 170,
      "relation": "association",
      "source": 1,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "TNT1 also co-localizes in tissue with the phospho-epitope defined by the AT8 antibody, indicating that PAD exposure represents an early event in AD pathology",
      "key": "e5d21349a8b8738ef7f92497a3484a3e",
      "line": 171,
      "relation": "association",
      "source": 1,
      "target": 25
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "We illustrate that Hsp70 preferentially binds to tau oligomers over filaments and prevents anterograde FAT inhibition observed with a mixture of both forms of aggregated tau",
      "key": "89d2df5b72e62473c36853e8a6f3a104",
      "line": 65,
      "relation": "decreases",
      "source": 13,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "However, our data indicate that Hsp70 preferentially binds to oligomeric as opposed to fibrillar tau aggregates and prevents anterograde FAT inhibition [31]",
      "key": "e240006ba7525bd3ad713d82937fd426",
      "line": 197,
      "relation": "increases",
      "source": 13,
      "target": 10
    },
    {
      "key": "11eb5113a65ad0b7de60242944ec6411",
      "relation": "partOf",
      "source": 3,
      "target": 13
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "Together, these findings support the hypothesis that tau oligomers are the toxic form of tau in neurodegenerative disease",
      "key": "4028c8df9c26a3b692460b3a20074d39",
      "line": 70,
      "relation": "increases",
      "source": 3,
      "target": 27
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "This indicates that tau oligomers represent the main toxic species responsible for neurodegeneration associated with AD",
      "key": "a12f57d22057bbe48d28f5c53291f220",
      "line": 203,
      "relation": "increases",
      "source": 3,
      "target": 27
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "Time-course aggregation analysis revealed that dimerization precedes tau oligomerization which, in turn, is an earlier event than the formation of full-length filaments",
      "key": "92f9f1e41d71458797a20ae175f24e27",
      "line": 107,
      "relation": "increases",
      "source": 3,
      "target": 1
    },
    {
      "key": "9ee7d96b19470fc095535ad631a00c33",
      "relation": "partOf",
      "source": 3,
      "target": 1
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "TOC1’s immunoreactivity is greatly elevated in AD brains compared with healthy controls, but co-localizes best with early-stage markers for AD pathogenesis such as pS422 [16]",
      "key": "7b8bd666267f1d2e0102e662c9a8d0f7",
      "line": 124,
      "relation": "association",
      "source": 3,
      "target": 24
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "TNT1 also co-localizes in tissue with the phospho-epitope defined by the AT8 antibody, indicating that PAD exposure represents an early event in AD pathology",
      "key": "49c4878e77fca610f1a6ddf4fa4ece5c",
      "line": 172,
      "relation": "association",
      "source": 3,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "TNT1 also co-localizes in tissue with the phospho-epitope defined by the AT8 antibody, indicating that PAD exposure represents an early event in AD pathology",
      "key": "ba9efb905f4f4c97a297c2f42eb0841e",
      "line": 173,
      "relation": "association",
      "source": 3,
      "target": 25
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "This indicates that tau oligomers represent the main toxic species responsible for neurodegeneration associated with AD",
      "key": "639a6079c61af6bcaf13c89ea1f6b9b6",
      "line": 204,
      "relation": "increases",
      "source": 3,
      "target": 12
    },
    {
      "key": "01f2745c7322b5f3ae736388813f827e",
      "relation": "partOf",
      "source": 19,
      "target": 13
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "Previous findings indicate that Hsp70 prevents tau toxicity by preserving tau in its soluble form and preventing it from aggregating by binding to exposed hydrophobic residues [33]",
      "key": "6b17e3f707c15b6b64d48f000a02538c",
      "line": 186,
      "relation": "decreases",
      "source": 19,
      "target": 1
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "It has also been demonstrated that Hsp70 can facilitate the degradation of pre-formed aggregates [33]",
      "key": "8861356210d6f787794945b67912d583",
      "line": 191,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 19,
      "target": 1
    },
    {
      "key": "d1580c05b0ecbd9fa43c8d3b6aa10699",
      "relation": "partOf",
      "source": 19,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Extracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "AD (Alzheimer’s disease) is a progressive neurodegenerative disorder characterized by the extracellular accumulation of senile plaques composed of Aβ (amyloid β-peptide) and the intracellular accumulation of the MAP (microtubuleassociated protein) tau into both non-filamentous and filamentous inclusions, such as NFTs (neurofibrillary tangles), NTs (neuropil threads) and NPs (neuritic plaques) [1,2]",
      "key": "42f96a55d0a5515ed7c7c4936cff6266",
      "line": 82,
      "relation": "positiveCorrelation",
      "source": 29,
      "target": 28
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "AD (Alzheimer’s disease) is a progressive neurodegenerative disorder characterized by the extracellular accumulation of senile plaques composed of Aβ (amyloid β-peptide) and the intracellular accumulation of the MAP (microtubuleassociated protein) tau into both non-filamentous and filamentous inclusions, such as NFTs (neurofibrillary tangles), NTs (neuropil threads) and NPs (neuritic plaques) [1,2]",
      "key": "e81b5b8f56c4369514227d45b166953d",
      "line": 84,
      "relation": "association",
      "source": 5,
      "target": 28
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "AD (Alzheimer’s disease) is a progressive neurodegenerative disorder characterized by the extracellular accumulation of senile plaques composed of Aβ (amyloid β-peptide) and the intracellular accumulation of the MAP (microtubuleassociated protein) tau into both non-filamentous and filamentous inclusions, such as NFTs (neurofibrillary tangles), NTs (neuropil threads) and NPs (neuritic plaques) [1,2]",
      "key": "aa0d179e6f6a74c012ab41d65752573f",
      "line": 85,
      "relation": "association",
      "source": 7,
      "target": 28
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "Tau’s primary role within neurons is thought to be the regulation and stabilization of microtubule dynamics [1,2]",
      "key": "6fa2218809fc215d3ae74a86cecaac14",
      "line": 91,
      "relation": "association",
      "source": 20,
      "target": 11
    },
    {
      "key": "064f60bbd4e86ec0d71e89e733af2e71",
      "relation": "hasVariant",
      "source": 20,
      "target": 22
    },
    {
      "key": "6e455396ea0f9f4eca01e280ccbdcfc3",
      "relation": "partOf",
      "source": 20,
      "target": 16
    },
    {
      "key": "0b23e783b6df6bf81703fab83a2f8726",
      "relation": "hasVariant",
      "source": 20,
      "target": 24
    },
    {
      "key": "4b30f73a8076f4c54eb2ee24961795ff",
      "relation": "hasVariant",
      "source": 20,
      "target": 21
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "Tau reportedly exerts an effect on axonal transport by interfering and reducing the attachment frequency of the motor proteins to the microtubules [28]",
      "key": "6ecd3c6c55e84e21b412ef2b494f30c0",
      "line": 154,
      "relation": "decreases",
      "source": 20,
      "target": 15
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "Tau reportedly exerts an effect on axonal transport by interfering and reducing the attachment frequency of the motor proteins to the microtubules [28]",
      "key": "ede7a8c6cc6f5e724a6f283c2fa71ca4",
      "line": 155,
      "relation": "decreases",
      "source": 20,
      "target": 14
    },
    {
      "key": "0e0ec3a09e8df8d002dd41b58ef30e38",
      "relation": "hasVariant",
      "source": 20,
      "target": 23
    },
    {
      "key": "66af6af91bc9c8705b42c7338defb2de",
      "relation": "hasVariant",
      "source": 20,
      "target": 25
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "Tau’s primary role within neurons is thought to be the regulation and stabilization of microtubule dynamics [1,2]",
      "key": "4e335b4d3904d9d2de71939b919d8ca6",
      "line": 91,
      "relation": "association",
      "source": 11,
      "target": 20
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "The tau protein becomes highly phosphorylated in AD and this is likely to induce a conformational change causing its detachment from microtubules and its accumulation in aggregates [3]",
      "key": "b03ccb106ebde0d11542ac02227cdced",
      "line": 99,
      "relation": "increases",
      "source": 22,
      "target": 1
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "Time-course aggregation analysis revealed that dimerization precedes tau oligomerization which, in turn, is an earlier event than the formation of full-length filaments",
      "key": "600209a1f388239962e37262af62a8c6",
      "line": 106,
      "relation": "increases",
      "source": 16,
      "target": 3
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "Employing recombinant full-length hT40, we observe the presence of oligomers approximately 15 min after the addition of the anionic inducer arachidonic acid, whereas filament formation requires 5–6 h to attain steady state (Figures 1A–1C)",
      "key": "d3c49fe63ecfb59abfa52c141a8ce8ee",
      "line": 115,
      "relation": "increases",
      "source": 0,
      "target": 3
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "Employing recombinant full-length hT40, we observe the presence of oligomers approximately 15 min after the addition of the anionic inducer arachidonic acid, whereas filament formation requires 5–6 h to attain steady state (Figures 1A–1C)",
      "key": "52e0c3e9d21bbff24b39d0295bf3a542",
      "line": 116,
      "relation": "increases",
      "source": 0,
      "target": 1
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "TOC1’s immunoreactivity is greatly elevated in AD brains compared with healthy controls, but co-localizes best with early-stage markers for AD pathogenesis such as pS422 [16]",
      "key": "5b2775ca36b7befc22c04e1d42a0f11f",
      "line": 124,
      "relation": "association",
      "source": 24,
      "target": 3
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "Further investigation illustrated that this inhibition occurs via activation of a signalling cascade involving PP1 (protein phosphatase 1) and GSK3 (glycogen synthase kinase 3) [24]",
      "key": "b2a3ac350ddbe916c56b2cc53a5b3b6a",
      "line": 138,
      "relation": "decreases",
      "source": 26,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "Further investigation illustrated that this inhibition occurs via activation of a signalling cascade involving PP1 (protein phosphatase 1) and GSK3 (glycogen synthase kinase 3) [24]",
      "key": "5acb098568b64818febec94c573dc1f9",
      "line": 139,
      "relation": "decreases",
      "source": 18,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": {
          "Low": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "Deletion analyses demonstrate that FAT inhibition requires a small stretch of amino acids (residues 2–18) located within the N-terminus that we have termed the PAD (phosphataseactivation domain) [21]",
      "key": "f64ddb7db5387ef251d4fb75120a80b2",
      "line": 148,
      "relation": "decreases",
      "source": 21,
      "target": 10
    },
    {
      "key": "ef0c266ed05c75f6af2b0a16e41c21a6",
      "relation": "partOf",
      "source": 21,
      "target": 17
    },
    {
      "key": "1649093d61f8f9c802557e39f8b4a780",
      "relation": "partOf",
      "source": 6,
      "target": 15
    },
    {
      "key": "84839f347edb1f6ef57a598bbf7ad536",
      "relation": "partOf",
      "source": 6,
      "target": 14
    },
    {
      "key": "c0d4ba559e2448ad87e01a8351bb8146",
      "relation": "partOf",
      "source": 9,
      "target": 15
    },
    {
      "key": "91e17606c8e867ae1644379e76ea8598",
      "relation": "partOf",
      "source": 8,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "TNT1 also co-localizes in tissue with the phospho-epitope defined by the AT8 antibody, indicating that PAD exposure represents an early event in AD pathology",
      "key": "a003294160359ebaddf681e20e20a454",
      "line": 170,
      "relation": "association",
      "source": 23,
      "target": 1
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "TNT1 also co-localizes in tissue with the phospho-epitope defined by the AT8 antibody, indicating that PAD exposure represents an early event in AD pathology",
      "key": "b48c313c3b9fe01d60bfd7b1435da577",
      "line": 172,
      "relation": "association",
      "source": 23,
      "target": 3
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "TNT1 also co-localizes in tissue with the phospho-epitope defined by the AT8 antibody, indicating that PAD exposure represents an early event in AD pathology",
      "key": "28939292e4564626135404bc8a9203ef",
      "line": 171,
      "relation": "association",
      "source": 25,
      "target": 1
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "TNT1 also co-localizes in tissue with the phospho-epitope defined by the AT8 antibody, indicating that PAD exposure represents an early event in AD pathology",
      "key": "dc5bc763411e461ff28d275b1120d56b",
      "line": 173,
      "relation": "association",
      "source": 25,
      "target": 3
    },
    {
      "key": "b20dc1b24492cf990aa04cf8c7174d33",
      "relation": "partOf",
      "source": 2,
      "target": 1
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Intracellular Space": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Binder LI",
          "Himmelstein DS",
          "Lancia JK",
          "Ward SM"
        ],
        "date": "2012-08-01",
        "db": "PubMed",
        "db_id": "22817713",
        "db_name": "Tau oligomers and tau toxicity in neurodegenerative disease.",
        "first": "Ward SM",
        "journal": "Biochemical Society transactions",
        "last": "Binder LI",
        "pages": "667-71",
        "volume": "40"
      },
      "evidence": "Furthermore, when Hsp70 was pre-incubated with the PAD peptide and introduced to the squid axoplasm, inhibition of FAT was still observed [31]",
      "key": "d964dc6fe999e66c541617c287dd3318",
      "line": 211,
      "relation": "decreases",
      "source": 17,
      "target": 10
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"arachidonic acid\")",
      "concept": {
        "name": "arachidonic acid",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "082e87b42d9c314316b9dc289d2a1f6d"
    },
    {
      "bel": "a(CONSO:\"Tau aggregates\")",
      "concept": {
        "name": "Tau aggregates",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "8e1da50e6008ffdd1b37825776666311"
    },
    {
      "bel": "a(CONSO:\"Tau fibrils\")",
      "concept": {
        "name": "Tau fibrils",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "1b18e2b527ac0db7353b67d4534c033e"
    },
    {
      "bel": "a(CONSO:\"Tau oligomers\")",
      "concept": {
        "name": "Tau oligomers",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "d45e1cc48bdfb58b4ead6900919dbbe3"
    },
    {
      "bel": "a(CONSO:\"amyloid-beta aggregates\")",
      "concept": {
        "name": "amyloid-beta aggregates",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "cb9ddfdb593aa8073305b79828d71376"
    },
    {
      "bel": "a(GO:\"neurofibrillary tangle\")",
      "concept": {
        "name": "neurofibrillary tangle",
        "namespace": "GO"
      },
      "function": "Abundance",
      "id": "274b01539a0746fbee06884b2af6c533"
    },
    {
      "bel": "a(GO:microtubule)",
      "concept": {
        "name": "microtubule",
        "namespace": "GO"
      },
      "function": "Abundance",
      "id": "0fe6be9622e5650da7dca7cdced2f9db"
    },
    {
      "bel": "a(MESH:\"Neuropil Threads\")",
      "concept": {
        "name": "Neuropil Threads",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "7a2395c6551685ba58951a397eaabc82"
    },
    {
      "bel": "a(MESH:Dyneins)",
      "concept": {
        "name": "Dyneins",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "2ba8e1d9146888e30372632d1123eaef"
    },
    {
      "bel": "a(MESH:Kinesin)",
      "concept": {
        "name": "Kinesin",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "a31f03dde42a4a94986145f81c34f994"
    },
    {
      "bel": "bp(GO:\"anterograde axonal protein transport\")",
      "concept": {
        "name": "anterograde axonal protein transport",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "35ebd956d85fb57273a53f4faf10d196"
    },
    {
      "bel": "bp(GO:\"regulation of microtubule cytoskeleton organization\")",
      "concept": {
        "name": "regulation of microtubule cytoskeleton organization",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "351eb7e4c06671894eee7242b07e2b41"
    },
    {
      "bel": "bp(HP:Neurodegeneration)",
      "concept": {
        "name": "Neurodegeneration",
        "namespace": "HP"
      },
      "function": "BiologicalProcess",
      "id": "d24e0a48dfe9951234e42f57ab8a2c78"
    },
    {
      "bel": "complex(a(CONSO:\"Tau oligomers\"), p(HGNC:HSPA1A))",
      "function": "Complex",
      "id": "7304cb5a9df8760d9570af0bec318760",
      "members": [
        {
          "bel": "a(CONSO:\"Tau oligomers\")",
          "concept": {
            "name": "Tau oligomers",
            "namespace": "CONSO"
          },
          "function": "Abundance",
          "id": "d45e1cc48bdfb58b4ead6900919dbbe3"
        },
        {
          "bel": "p(HGNC:HSPA1A)",
          "concept": {
            "name": "HSPA1A",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "966fe209577a96fd2393e8ca0c76bf49"
        }
      ]
    },
    {
      "bel": "complex(a(GO:microtubule), a(MESH:Dyneins))",
      "function": "Complex",
      "id": "5010b289193a584e7205b9d0473dbc95",
      "members": [
        {
          "bel": "a(GO:microtubule)",
          "concept": {
            "name": "microtubule",
            "namespace": "GO"
          },
          "function": "Abundance",
          "id": "0fe6be9622e5650da7dca7cdced2f9db"
        },
        {
          "bel": "a(MESH:Dyneins)",
          "concept": {
            "name": "Dyneins",
            "namespace": "MESH"
          },
          "function": "Abundance",
          "id": "2ba8e1d9146888e30372632d1123eaef"
        }
      ]
    },
    {
      "bel": "complex(a(GO:microtubule), a(MESH:Kinesin))",
      "function": "Complex",
      "id": "be3b854e6c6b9dcd375db01014817bd4",
      "members": [
        {
          "bel": "a(GO:microtubule)",
          "concept": {
            "name": "microtubule",
            "namespace": "GO"
          },
          "function": "Abundance",
          "id": "0fe6be9622e5650da7dca7cdced2f9db"
        },
        {
          "bel": "a(MESH:Kinesin)",
          "concept": {
            "name": "Kinesin",
            "namespace": "MESH"
          },
          "function": "Abundance",
          "id": "a31f03dde42a4a94986145f81c34f994"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:MAPT), p(HGNC:MAPT))",
      "function": "Complex",
      "id": "2218a553afef0da4b62d5115971b2947",
      "members": [
        {
          "bel": "p(HGNC:MAPT)",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7d1009217050e75d549c8c5aa83309a8"
        },
        {
          "bel": "p(HGNC:MAPT)",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7d1009217050e75d549c8c5aa83309a8"
        }
      ]
    },
    {
      "bel": "composite(p(HGNC:HSPA1A), p(HGNC:MAPT, frag(\"2_18\")))",
      "function": "Composite",
      "id": "562476aa69f1c6908515e1841909d58f",
      "members": [
        {
          "bel": "p(HGNC:HSPA1A)",
          "concept": {
            "name": "HSPA1A",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "966fe209577a96fd2393e8ca0c76bf49"
        },
        {
          "bel": "p(HGNC:MAPT, frag(\"2_18\"))",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7d8fec313e68a80047de866c92d16ffa",
          "variants": [
            {
              "kind": "frag",
              "start": 2,
              "stop": 18
            }
          ]
        }
      ]
    },
    {
      "bel": "p(HGNC:GSK3A)",
      "concept": {
        "name": "GSK3A",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "ce7c231328d7b0e85ffd798a554023bd"
    },
    {
      "bel": "p(HGNC:HSPA1A)",
      "concept": {
        "name": "HSPA1A",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "966fe209577a96fd2393e8ca0c76bf49"
    },
    {
      "bel": "p(HGNC:MAPT)",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "7d1009217050e75d549c8c5aa83309a8"
    },
    {
      "bel": "p(HGNC:MAPT, frag(\"2_18\"))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "7d8fec313e68a80047de866c92d16ffa",
      "variants": [
        {
          "kind": "frag",
          "start": 2,
          "stop": 18
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "a8fb3a87d5a0672c07462bb17c8b0947",
      "variants": [
        {
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 202))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "cdcc3b3f116c5db02d04ca383584aef0",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 202
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 422))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "393be594a81d2f0c5386c424aa4cc22b",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 422
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Thr, 205))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "18a670a34dac41b169d64c4316bdf50c",
      "variants": [
        {
          "code": "Thr",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 205
        }
      ]
    },
    {
      "bel": "p(HGNC:PPP1CA)",
      "concept": {
        "name": "PPP1CA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "5404262cc0165ae1901b3dd29ef56b36"
    },
    {
      "bel": "path(CONSO:neurotoxicity)",
      "concept": {
        "name": "neurotoxicity",
        "namespace": "CONSO"
      },
      "function": "Pathology",
      "id": "f092504a78142cc0cb1a590cf3b073d3"
    },
    {
      "bel": "path(MESH:\"Alzheimer Disease\")",
      "concept": {
        "name": "Alzheimer Disease",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "2ae8307f5fd59056199369691367cc96"
    },
    {
      "bel": "path(MESH:\"Plaque, Amyloid\")",
      "concept": {
        "name": "Plaque, Amyloid",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "ff45c3caeb411cd232d96d6ed01854d5"
    }
  ]
}